Journal decision profile

Neuropeptides

Medicine · Neuroscience

Neuropeptides' 2026 Journal Metrics Score is 3.0, ranking Q1 in Social Psychology. Two-year citation average from OpenAlex data, updated August 2026.

Elsevier BVUnited KingdompISSN 0143-4179eISSN 1532-2785
Checking system sharing availability.Visit homepage

Bookmark this page — track observed submission-to-acceptance timing, FWCI and field-normalized citation data for this journal in one view.

Journal Metrics Score
i
Journal Metrics ScoreThe raw score is citations received in the latest complete year by works from the two previous years, divided by the number of those works. It is calculated from OpenAlex open data (CC0) and is not a percentage grade.
2026
3.0

Journal Metrics Score 2026 · 2021–2024 window citedness 2.53.

Review & acceptance time
i
Review & acceptance timeCalendar days between the received and accepted dates reported in recent PubMed records. This interval includes editorial handling and author revisions, so it is not time to first decision or pure peer-review time.
PUBMED
74 daysmedian

Middle 50%: 51–107 days

100 of 100 PubMed-indexed articles · 100% coverage · 2024–2025

Neuropeptides accepts papers a median of 74 days after submission, including peer review and revisions. That is faster than 91% of comparable journals with PubMed timing data.

Indicative APC
i
Indicative APCThis journal-level estimate comes from the OpenAlex source record. It is not a verified quote and may exclude taxes, waivers, society discounts, or article-type charges. Check the journal's official website before deciding.
OPENALEX · VERIFY
$3,530

Journal-level estimate only. Verify current charges, taxes, waivers, discounts, and article-type fees with the journal.

Free preview · no sign-in

Does your manuscript fit Neuropeptides?

Paste your title to see which of this journal's published topics it overlaps with. Your title stays in your browser for this preview and is not sent anywhere.

Want ranked journals with fit reasons, risks and a submission strategy instead? See a sample AI report.

At a glance

Journal decision profile

Each spoke is a 0–100 percentile within a comparable journal cohort—not a percentage grade or a single black-box rating.

Relative profile

Metrics ScoreThe raw 2026 Journal Metrics Score is the recent two-year citation average shown above. The radar converts it to a 0–100 cohort percentile: farther out means a higher score than more comparable journals. It is not a percentage grade.iSource outputThe raw rank compares lifetime output inside the journal’s leading-topic source set. The radar then compares that rank position across Decision Profile journals in the same primary OpenAlex field; when that field has too few profiles, it uses the broader profile set. Farther out means relatively more output, not better research quality.iTop 10% shareThe share of recent papers in the global top 10% for citations after comparing papers of the same type, publication year, and subfield. The radar converts that share to a 0–100 cohort percentile; it does not predict how a new paper will perform.iMedian FWCICitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected citation level for comparable papers; the radar shows its 0–100 cohort percentile.iSubmission-to-acceptanceCalendar days from the received date to the accepted date in recent PubMed records. This includes editorial handling and author revisions, so it is not the time to first decision and not pure peer-review time. The radar uses a 0–100 cohort percentile with shorter observed timing plotted farther out; it does not measure review quality.iOutput volumeAverage works published per year in the recent analysis window, converted to a 0–100 cohort percentile. Farther out means the journal publishes more papers; it does not mean those papers are better.i
Cost is intentionally excluded. Missing APC data is never converted to a zero-dollar fee or a fabricated cost score.

Raw values behind the shape

Always visible
Metrics Score
i
Metrics ScoreThe 2026 raw Journal Metrics Score shown above. The bar is its 0–100 percentile within the radar's comparable journal cohort; it is not a percentage score.
3.02026 · OPENALEX
Source output rank
i
Source output rankThis lifetime journal-wide output rank compares works published by the OpenAlex source with sources associated with the journal’s leading topic. More output does not mean higher quality.
#152 / 823LIFETIME OUTPUT
Highly cited papers
i
Highly cited papersShare of recent works in the global top 10% for citations after comparing papers of the same type, publication year, and subfield.
9.8%FIELD-NORMALIZED TOP 10%
Field-normalized impact
i
Field-normalized impactCitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected level for comparable work.
0.74MEDIAN FWCI
Submission-to-acceptance
i
Submission-to-acceptanceReceived-to-accepted calendar days from qualified PubMed records. It includes editorial handling and author revisions; it is not time to first decision or pure peer-review time.
74 daysIQR 51–107 DAYS
Recent output
i
Recent outputAverage works published per year across the complete analysis window. This is a volume measure, not a quality score.
59 / yr2021–2024 AVG
Field-normalized top 10% share9.8%

23 of 234 works · same type, year & subfield

Field-normalized top 1% share0%

0 works · same type, year & subfield

Median FWCI0.74×

Below field-year expectation

Source output rank#152

of 823 topic-associated OpenAlex sources by lifetime output

What does Median FWCI mean?

FWCI compares papers with the same publication year, type, and field. 1.0 is the world average; above 1.0 is above expectation. This journal's median is 0.74, so its typical recent paper runs about 26% below its field benchmark.

What does Top 10% Share mean?

9.8% of recent papers rank in the global top 10% after field normalization. This is easier to compare across specialties than raw citation totals.

Publishing pattern

Publication volume and article mix

Volume is separated from citation accumulation so newer papers are not presented as weaker simply because they are newer.

Works published by year

OpenAlex source records · 2016–2025

1712016
1442017
742018
722019
612020
662021
582022
502023
602024
532025

Recent work-type mix

234 OpenAlex works · 2021–2024

Article87.6%
Paratext10.3%
Retraction0.9%
Editorial0.4%
Erratum0.4%
Review0.4%
OpenAlex article is broader than “original research.” PubMed Publication Types can add case-report and clinical-study detail.
Fit signals

Topics and medical subject coverage

OpenAlex topics show research communities; MeSH keeps the medical taxonomy recognizable.

Major MeSH signals

PubMed-indexed works

Select a MeSH signal to see how much Neuropeptides publishes on it, from PubMed counts for the last five complete years.

Leading OpenAlex topics

2021–2024 works
Neuropeptides and Animal Physiology34
Regulation of Appetite and Obesity18
Pain Mechanisms and Treatments15
Alzheimer's disease research and treatments12
Parkinson's Disease Mechanisms and Treatments8
Hypothalamic control of reproductive hormones7
Neuroscience and Neuropharmacology Research7
Apelin-related biomedical research5
Healthcare and Venom Research5
Spinal Cord Injury Research5
Methodology: OpenAlex snapshot 2026-10-16. FWCI, percentile badges, topics, and type mix use 234 works published 2021–2024. Radar normalization is versioned in the cached profile, and no cost score is assigned without reliable APC data.

Subject Category Quartiles

Quartiles computed within each OpenAlex subfield
CategoryQuartile
Cellular and Molecular NeuroscienceQ2
Molecular BiologyQ2
Endocrine and Autonomic SystemsQ2
Social PsychologyQ1

Is Neuropeptides a good journal?

Yes. A Q1 journal by citation data

Yes. By citation data, Neuropeptides is a strong journal: it is Q1 in Social Psychology and ranks #328 of 1,171 Neuroscience journals by Journal Metrics Score (top 29%). Neuropeptides' 2026 Journal Metrics Score is 3.0. Recent papers took a median of 74 days from submission to acceptance, according to PubMed dates. OpenAlex lists an indicative article processing charge of $3,530 USD. OpenAlex classifies its papers in subfields including Cellular and Molecular Neuroscience, Molecular Biology, and Endocrine and Autonomic Systems, so check that your topic fits its scope.

Best quartile
Q1
Social Psychology
Rank in Neuroscience
#328 of 1,171
Top 29%
2026 Journal Metrics Score
3.0
Acceptance rate
Not published
By the journal or publisher
Submission to acceptance
74 days
Median, PubMed records
Indicative APC
$3,530
OpenAlex, verify with the journal
Papers published in 2025
53
OpenAlex works

Check before you submit

  • Confirm the current article processing charge, waivers, and any institutional agreement on the journal website; the OpenAlex figure is indicative.
  • Confirm the journal is indexed where your institution or funder requires (for example Scopus or PubMed) before you submit.

Verdict from citation data only: quartile and field rank by Journal Metrics Score (OpenAlex), publisher-reported acceptance rates, and PubMed submission and acceptance dates. See how we rank journals and how to verify indexing.

Q1
Subfield Quartile
B3
CAS Block

Ranking and source check

#328
of 1,171 Neuroscience field journals
#316
among Q1 Neuroscience journals

Confirm the exact title and ISSNs against the publisher homepage before a high-stakes submission decision.

Journal Details

OpenAlex Works
4,412
H-Index
104
Fully Open Access
No
Recent OA Works
298
Subject Areas
Cellular and Molecular NeuroscienceMolecular BiologyEndocrine and Autonomic SystemsSocial Psychology

Source: the current OpenAlex source record. OpenAlex works can include multiple work types. Fully Open Access is a source-level flag. Recent OA Works is summed from OpenAlex's counts_by_year series (up to the latest ten years); it is not a lifetime OA percentage. Any APC shown here is an indicative OpenAlex value—verify current charges on the journal's official website.

How to submit to Neuropeptides

  1. 1

    Check the scope

    OpenAlex classifies Neuropeptides' papers in subfields including Cellular and Molecular Neuroscience, Molecular Biology, and Endocrine and Autonomic Systems. Read the aims and scope page and a few recent papers close to your topic before you prepare the manuscript.

  2. 2

    Follow the author guidelines

    Article types, word and figure limits, reference style, and the required statements (data availability, ethics, conflicts of interest, author contributions) are set by the journal. Prepare the cover letter and files to match them.

    Neuropeptides homepage ↗
  3. 3

    Submit through Editorial Manager

    Most Elsevier and Cell Press journals take submissions through Editorial Manager; each journal has its own site, reached from Submit your article on the journal homepage.

  4. 4

    Plan for costs

    OpenAlex lists an indicative article processing charge of $3,530 USD. Check the current fee, waivers, and any institutional agreement on the journal website.

  5. 5

    Know what to expect

    Recent accepted papers took a median of 74 days from submission to acceptance, including revisions (PubMed dates). Neuropeptides does not publish an acceptance rate.

Submission system from the publisher's author information, checked 2026-10-27. Individual journals can differ, so follow the link in the journal's own author guidelines.

New on PubMed

What's new in your field?

Type a topic to see the newest PubMed papers from the past week and the big picture of what they found, summarized by Claude on the Pro plan. Get a free weekly email to keep up.

See a demo:GLP-1CRISPRLong COVID

Reviewer Two · coming soon

Know what reviewers will say before you submit to Neuropeptides

An AI pre-submission report on your manuscript: the objections a tough reviewer is likely to raise, desk-rejection risks, and better-fit journals from our data. $29 per report.

See what the report covers

Common questions about Neuropeptides

Is Neuropeptides a good journal?

Yes. By citation data, Neuropeptides is a strong journal: it is Q1 in Social Psychology and ranks #328 of 1,171 Neuroscience journals by Journal Metrics Score (top 29%). Neuropeptides' 2026 Journal Metrics Score is 3.0. Recent papers took a median of 74 days from submission to acceptance, according to PubMed dates. OpenAlex lists an indicative article processing charge of $3,530 USD. OpenAlex classifies its papers in subfields including Cellular and Molecular Neuroscience, Molecular Biology, and Endocrine and Autonomic Systems, so check that your topic fits its scope.

What is Neuropeptides' Journal Metrics Score in 2026?

Neuropeptides' 2026 Journal Metrics Score is 3.0, from the August 2026 data release. The score is a two-year citation average computed from OpenAlex (CC0) data: citations received in the most recent complete year to works published in the two prior years, divided by the number of those works.

What is the acceptance rate of Neuropeptides?

We have not found an official acceptance rate published by Neuropeptides or its publisher, and Journal Metrics does not estimate one because submission counts are not public. What recent PubMed records do show is speed: accepted papers took a median of 74 days from submission to acceptance. To judge selectivity, compare Neuropeptides' quartile and score with similar journals, or ask the editorial office.

What quartile is Neuropeptides in?

Neuropeptides' best quartile is Q1. By OpenAlex subfield: Q2 in Cellular and Molecular Neuroscience; Q2 in Molecular Biology; Q2 in Endocrine and Autonomic Systems; Q1 in Social Psychology. Quartiles rank journals by Journal Metrics Score within each subfield.

Is the Journal Metrics Score the same as other journal citation metrics?

No. Journal Metrics computes the score independently from OpenAlex open data. Other providers use different citation databases, document types, and counting rules, so their published figures for Neuropeptides will not match this score exactly. Compare journals using one source at a time.

How long does Neuropeptides take to accept a paper?

Neuropeptides accepts papers a median of 74 days after submission across 100 recent PubMed records with both dates; the middle half took 51–107 days. This includes peer review, editorial handling, and revisions.

How long is the peer review time at Neuropeptides?

PubMed records when a manuscript was received and accepted, not the individual review stages, so peer review time on its own is not available. The full time from submission to acceptance at Neuropeptides, which includes peer review and revisions, has a median of 74 days. For the time to a first decision, check the journal's own website.

Is Neuropeptides faster than similar journals?

Neuropeptides' median of 74 days from submission to acceptance is faster than 91% of comparable journals with PubMed timing data.

How much does it cost to publish in Neuropeptides?

OpenAlex lists an indicative article processing charge of $3,530 USD for Neuropeptides. This journal-level estimate may exclude taxes, waivers, discounts, or article-type fees, so confirm the current charge on the journal's website.

Which journals are alternatives to Neuropeptides?

Comparable journals include Frontiers in Molecular Neuroscience, Ibro Neuroscience Reports, Journal of Chemical Neuroanatomy, and Neuroscience Letters. Compare their scores, acceptance times, and costs in the recommended alternatives on this page before choosing where to submit.

How do I submit a paper to Neuropeptides?

Most Elsevier and Cell Press journals take submissions through Editorial Manager; each journal has its own site, reached from Submit your article on the journal homepage. Before submitting, check the scope, follow the author guidelines for article type, length, and required statements, and prepare a cover letter. Accepted papers took a median of 74 days from submission to acceptance in recent PubMed records.

Cite an article from this journal
Back to Search